Profil
Thomas Uhlin was the Chief Executive Officer of Aprea Therapeutics AB and held Principal positions at Orexo AB and Doxa AB.
Ehemalige bekannte Positionen von Thomas Uhlin
| Unternehmen | Position | Ende |
|---|---|---|
| OREXO AB | Corporate Officer/Principal | - |
| DOXA AB | Corporate Officer/Principal | - |
Aprea Therapeutics AB
Aprea Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops novel anticancer compounds | Präsident | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Orexo AB
Orexo AB Pharmaceuticals: MajorHealth Technology Manufactures and commercializes pharmaceutical products | Health Technology |
Doxa AB
Doxa AB Medical SpecialtiesHealth Technology Develops, manufactures, and commercializes bio ceramic dental products | Health Technology |
Aprea Therapeutics AB
Aprea Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops novel anticancer compounds | Health Technology |
















